BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9158996)

  • 1. Systematic review of finasteride effect in women with hirsutism.
    Soares Júnior JM; Guimarães DZ; Simões RDS; Veiga ECA; Roa CL; Sorpreso ICE; Baracat MC; Baracat EC
    Rev Assoc Med Bras (1992); 2021 Jul; 67(7):1043-1049. PubMed ID: 34817521
    [No Abstract]   [Full Text] [Related]  

  • 2. Finasteride. Does it affect spermatogenesis and pregnancy?
    Pole M; Koren G
    Can Fam Physician; 2001 Dec; 47():2469-70. PubMed ID: 11785276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.
    Meidan VM; Touitou E
    Drugs; 2001; 61(1):53-69. PubMed ID: 11217871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5 alpha-reductase and finasteride in pattern alopecia and acne.
    Burkhart CG; Burkhart CN
    J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia.
    Krausz A; Friedman AJ
    J Drugs Dermatol; 2013 Nov; 12(11):1297-300. PubMed ID: 24358489
    [No Abstract]   [Full Text] [Related]  

  • 6. 5 alpha-reductase inhibitors--a new hope in dermatology?
    Amichai B; Grunwald MH; Sobel R
    Int J Dermatol; 1997 Mar; 36(3):182-4. PubMed ID: 9158996
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
    Azzouni F; Zeitouni N; Mohler J
    J Drugs Dermatol; 2013 Feb; 12(2):e30-5. PubMed ID: 23377402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.
    Chen W; Zouboulis CC; Orfanos CE
    Dermatology; 1996; 193(3):177-84. PubMed ID: 8944337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
    Buzney E; Sheu J; Buzney C; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.